Skip to main content
SpringerLink
Log in

Pitfalls in the Design, Conduct and Analysis of Randomised Clinical Trials

  • Chapter
Advances in Radiation Oncology in Lung Cancer

Part of the book series: Medical Radiology Radiation Oncology ((Med Radiol Radiat Oncol))

  • 874 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anderson H, Hopwood P, Stephens RJ, Thatcher N, Cottier B, et al. (2000) Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer — a randomized trial with quality of life as the primary outcome. Br J Cancer 83:447–453

    Article  PubMed  Google Scholar 

  • Cancer Therapy Evaluation Programme (2003) Common Terminology Criteria for Adverse Events. Version 3.0. DCTD, NCI, NIH, DHHS. March 31 2003. http://ctep.cancer.gov/

    Google Scholar 

  • Clarke M, Chalmers I (1998) Discussion sections in reports of controlled trials published in general medical journals: islands in search of continents? JAMA 280:280–282

    Article  PubMed  Google Scholar 

  • Clarke M, Alderson P, Chalmers I (2002) Discussion sections in reports of controlled trial published in general medical journals. JAMA 287:2799–2801

    Article  PubMed  Google Scholar 

  • Fossella FV, DeVore R, Kerr RN, Crawford J, Natale RR, et al. (2000) Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens. J Clin Oncol 18:2354–2362

    PubMed  Google Scholar 

  • Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, et al. (2003) Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small cell lung cancer. J Clin Oncol 21:2237–2246

    Article  PubMed  Google Scholar 

  • Gatzemeier U, von Pawel J, Gottfried M, ten Velde GPM, Mattson K, et al. (2000) Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small cell lung cancer. J Clin Oncol 18:3390–3399

    PubMed  Google Scholar 

  • Georgoulias V, Papadakis E, Alexopoulos A, Tsiafaki X, Rapti A, et al. (2001) Platinum-based and non-platinum-based chemotherapy in advanced non-small cell lung cancer: a randomised multicentre trial. Lancet 357:1478–1484

    Article  PubMed  Google Scholar 

  • Kelly K, Crowley J, Bunn Jr PA, Presant CA, Grevstad PK, et al. (2001) Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a South-west Oncology Group trial. J Clin Oncol 19:3210–3218

    PubMed  Google Scholar 

  • Langendijk H, de Jong J, Tjwa M, Muller M, ten Velde G, et al. (2001) External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Rad Oncol 58:257–268

    Article  Google Scholar 

  • Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311:899–909

    Google Scholar 

  • Pujol J-L, Daures J-P, Riviere A, Quoix E, Westell V, et al. (2001) Etoposide plus cisplatin with or without the combination of 4′-epidoxorubicin plus cyclophosphamide in treatment of extensive small cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study. J Natl Cancer Inst 93:300–308

    Article  PubMed  Google Scholar 

  • Ranson M, Davidson N, Nicolson M, Falk S, Carmichael J, et al. (2000) Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small cell lung cancer. J Natl Cancer Inst 92:1074–1080

    Article  PubMed  Google Scholar 

  • Rosell R, Gomez-Condina J, Camps C, Maestre J, Padilla J, et al. (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330:153–158

    PubMed  Google Scholar 

  • Roszkowski K, Pluzanska A, Krzakowski M, Smith AP, Saigi E, et al. (2000) A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC). Lung Cancer 27:145–157

    Article  PubMed  Google Scholar 

  • Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB, et al. (1994) A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIa non-small cell lung cancer. J Natl Cancer Inst 86:673–680

    PubMed  Google Scholar 

  • Sandler AB, Nemunaitis J, Denham C, von Pawel J, Cormier Y, et al. (2000) Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small cell lung cancer. J Clin Oncol 18:122–130

    PubMed  Google Scholar 

  • Sause W, Kolesar P, Taylor S IV, Johnson D, Livingston R, et al. (2000) Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest 117:358–364

    Article  PubMed  Google Scholar 

  • Scagliotti GV, Fossati R, Torri V, Crino L, Giaccone G, et al. (2003) Randomized study of adjuvant chemotherapy for completely resected stage I, II or IIIa non-small cell lung cancer. J Natl Cancer Inst 95:1453–1461

    PubMed  Google Scholar 

  • Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, et al. (2002) Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med 346:92–98

    Article  PubMed  Google Scholar 

  • Sculier JP, Paesmans M, Lecomte J, van Cutsem O, Lafitte JJ, et al. (2001) A three-arm phase III randomised trial assessing, in patients with extensive disease small cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics. Br J Cancer 85:1444–1451

    Article  PubMed  Google Scholar 

  • Shepherd FA, Giaccone G, Seymour L, Debruyne C, Bezjak A, et al. (2002) Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small cell lung cancer: a trial of the national Cancer Institute of Canada — Clinical Trials group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 20:4434–4439

    PubMed  Google Scholar 

  • Socinski MA, Schell MJ, Peterman A, Bakri K, Yates S, et al. (2002) Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced stage IIIb/IV non-small cell lung cancer. J Clin Oncol 20:1335–1343

    PubMed  Google Scholar 

  • Souquet PJ, Tan EH, Rodrigues Pereira J, van Klaveren R, Price A, et al. (2002) GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small cell lung cancer patients. Ann Oncol 13:1853–1861

    Article  PubMed  Google Scholar 

  • Splinter TA, Sahmoud T, Festen J, van Zandwijk N, Sorenson S, et al. (1996) Two schedules of teniposide with or without cisplatin in advanced non-small cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 14:127–134

    PubMed  Google Scholar 

  • Stephens R (2004) Quality of life issues in non-small cell lung cancer. Expert Rev Pharmacoeconomics Outcomes Res 4:89–100

    Article  Google Scholar 

  • Sundstrom S, Bremnes RM, Kaasa S, Aasebo U, Hatlevoll R, et al. (2002) Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin and vincristine regimen in small cell lung cancer: results from a randomized phase III trial with 5 years’ follow-up. J Clin Oncol 20:4665–4672

    PubMed  Google Scholar 

  • Tada H, Tsuchiya R, Ichinose Y, Koike T, Nishizawa N, Nagai K, Kato H (2004) A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304). Lung Cancer 43:167–173

    Article  PubMed  Google Scholar 

  • Takada M, Fukuoka M, Kawahara M, Sugiura T, Yokoyama A, et al. (2002) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited stage small cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20:3054–3060

    Article  PubMed  Google Scholar 

  • Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, et al. (2000) New guidelines to evaluate the response to treatment in sold tumours. J Natl Cancer Inst 92:205–216

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Division, MRC Clinical Trials Unit, 222 Euston Road, London, NW1 2DA, UK

    Richard Stephens (Research Scientist)

Authors
  1. Richard Stephens
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 226, 81657, München, Germany

    Branislav Jeremić MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stephens, R. (2005). Pitfalls in the Design, Conduct and Analysis of Randomised Clinical Trials. In: Jeremić, B. (eds) Advances in Radiation Oncology in Lung Cancer. Medical Radiology Radiation Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26632-1_39

Download citation

  • DOI: https://doi.org/10.1007/3-540-26632-1_39

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-00522-3

  • Online ISBN: 978-3-540-26632-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation